Finances
-
Deep Dive
Medicaid overtakes Medicare Advantage as health insurers’ bogeyman in Q2
Despite challenges in Medicaid and MA, major insurers still posted large earnings in the second quarter — many helped by health services divisions.
By Rebecca Pifer • Aug. 15, 2024 -
Kaiser’s operating margin rises to 3.1% in second quarter
The nonprofit healthcare giant's results represent a strong quarter and a solid end to the first half of the year, one analyst said.
By Susanna Vogel • Aug. 13, 2024 -
For-profit health systems see Medicaid supplemental payment bump in Q2
However, hospital executives said the uptick in supplemental funding still wasn’t enough to cover their costs.
By Susanna Vogel • Aug. 12, 2024 -
Nonprofits’ cash on hand hit 10-year low in 2023: report
S&P Global also found no "meaningful" improvement in cash flow for providers between 2022 and 2023.
By Susanna Vogel • Aug. 12, 2024 -
After decline, private equity investment in healthcare reaches turning point: PitchBook
Private equity dealmaking fell more than 16% in the second quarter, but the market is showing signs of a turnaround, according to the market research firm.
By Emily Olsen • Aug. 9, 2024 -
Walgreens considering full sale of VillageMD
The decision, disclosed Wednesday in a securities filing, is a sharp reversal to the pharmacy behemoth’s past commitment to building out its healthcare delivery offerings.
By Rebecca Pifer • Aug. 8, 2024 -
Aetna executive ousted as CVS’ Medicare Advantage woes drag into second quarter
On Wednesday, CVS slashed its earnings guidance for the third time this year, announced a plan to cut $2 billion in costs and fired the head of its insurance division Aetna, which continues to struggle with high medical utilization.
By Rebecca Pifer • Aug. 7, 2024 -
More than 700 rural hospitals at risk of closing: report
One challenge hospitals face is reimbursement from private payers, which doesn’t cover the higher costs of care in rural areas, according to a report by the Center for Healthcare Quality and Payment Reform.
By Emily Olsen • Aug. 7, 2024 -
Tenet to sell majority stake in 5 Alabama hospitals for $910M
The health system has divested a string of hospitals this year as it seeks to pay down debt and refocus its portfolio on ambulatory surgery centers.
By Susanna Vogel • Aug. 6, 2024 -
Walgreens further reduces stake in Cencora for $1.1B
The struggling drugstore chain has been chipping away at its stake in Cencora, formerly known as AmerisourceBergen, since last summer.
By Rebecca Pifer • Aug. 5, 2024 -
Medicare finalizes higher 2.9% inpatient payment rate for 2025
Hospitals still weren’t happy with the final rule despite the bump from the CMS’ proposed rates, citing cuts to long-term and disproportionate share facilities.
By Rebecca Pifer • Aug. 2, 2024 -
Cigna CEO promises ‘aggressive’ defense of pharmacy benefit managers
David Cordani’s comments to investors Thursday come as the payer blew past Wall Street’s expectations for the second quarter, helped by significant growth in its health services division — including PBM Express Scripts.
By Rebecca Pifer • Aug. 1, 2024 -
Tracking Steward's decline
Judge approves Steward’s plan to close 2 hospitals by month’s end
Steward also provided an update on increasingly tense negotiations with its landlord about how to distribute proceeds from sales.
By Susanna Vogel • Aug. 1, 2024 -
Humana expects to lose ‘few hundred thousand’ Medicare Advantage members next year
The insurer shrank its plan footprint for 2025 in a bid to improve margins. Now, Humana is giving market watchers loose guidance into how that reduction could affect its enrollment along with second quarter results.
By Rebecca Pifer • July 31, 2024 -
Google cuts ties with Amazon’s One Medical
Loss of the contract is a major setback for One Medical, as Google made up roughly 10% of the company’s revenue before it was acquired by Amazon and stopped disclosing financial results.
By Rebecca Pifer • Updated July 31, 2024 -
CHS trims losses in second quarter
The health system posted a $13 million net loss, even as surgical and outpatient volumes climbed.
By Susanna Vogel • July 29, 2024 -
Growth in ACA plans keeps Medicaid giant Centene from worst of redeterminations impact
Centene continued to deal with a mismatch between Medicaid rates and patient acuity in the second quarter, but still exceeded Wall Street’s expectations thanks to Affordable Care Act growth.
By Rebecca Pifer • July 26, 2024 -
UHS says demand for services ‘moderating’ at acute hospitals in Q2
The health system reported a net income of $289.2 million in the second quarter, but relatively flat patient volume growth sparked analyst concerns during an earnings call Thursday.
By Susanna Vogel • July 25, 2024 -
Tenet raises full-year earnings guidance again
Tenet has an emerging “beat and raise” track record on Wall Street, analysts said.
By Susanna Vogel • July 25, 2024 -
Molina’s Medicaid growth offsets worst of redeterminations pressures in Q2
The California-based insurer also outlined how it remains acquisitive, despite recently sharing plans to purchase ConnectiCare.
By Rebecca Pifer • July 25, 2024 -
HCA posts $17.5B in Q2 revenue and raises full-year guidance
The Nashville, Tennessee-based provider attributed the stronger-than-expected results to increased patient volumes.
By Susanna Vogel • July 23, 2024 -
S&P Global Ratings downgrades Walgreens, citing struggles in both pharmacy and retail
The drugstore retailer faces debt maturities, while the upending of some strategies introduces new uncertainties, analysts said.
By Daphne Howland • July 23, 2024 -
Digital health funding declines, but check sizes swell: CB Insights
While the number of deals reached its lowest levels since 2014, the average deal size for the first half of 2024 was 40% higher than the year prior.
By Emily Olsen • July 19, 2024 -
Elevance hits $2.3B in profit but trims long-term guidance
Elevance beat Wall Street expectations in second-quarter results posted Wednesday, despite steep Medicaid membership losses that are affecting revenue forecasts.
By Rebecca Pifer • July 17, 2024 -
UnitedHealth’s cyberattack response costs to surpass $2.3B this year
The healthcare giant’s new estimate is roughly $1 billion higher than previous forecasts as the cyberattack on subsidiary Change Healthcare continues to hamper its profit outlook.
By Rebecca Pifer • July 16, 2024